APOE and Alzheimer's Risk: What the Research Actually Says

Of everything MyGeneLog can surface, an APOE result is the one most worth reading carefully before drawing conclusions — which is exactly why it's kept behind an explicit "reveal" step in the app.

What APOE is

APOE isn't a single SNP — it's a combination of two positions (rs429358 and rs7412) that together define three common versions of the gene: e2, e3, and e4. Everyone carries two copies (one from each parent), so your APOE status is a pair like e3/e3, e3/e4, or e4/e4.

What the research actually shows

Corder and colleagues established in 1993 that carrying the e4 version is associated with meaningfully elevated lifetime risk of late-onset Alzheimer's disease compared to the e3/e3 baseline, and that risk rises further with two e4 copies. The e2 version, by contrast, is associated with somewhat reduced risk relative to baseline.

What this does not tell you

This is the part that matters most: APOE status does not predict whether you will develop Alzheimer's, and it absolutely does not predict when. Plenty of e4 carriers never develop the disease, and plenty of people who develop it carry no e4 at all. It's a risk modifier measured across large populations, not a personal forecast.

What's actually worth doing with this result

This is squarely a "talk to a doctor or a genetic counselor" result, not a "search the internet at 2am" result. A genetic counselor can walk through what it does and doesn't mean for your specific situation and family history — which is precisely the kind of context a single genotype can't provide on its own.